Suzanne Bujara

Contributing Writer https://www.thecardiologyadvisor.com

Suzanne Bujara is a medical writer with more than 20 years of experience. She writes for continuing medical education and public health programs. She has a BA in linguistics from Douglass College, Rutgers, The State University of New Jersey and an MBA from Rutgers Business School. Before starting her freelance business in 2016, Suzanne wrote for Medscape Education, myCME, praxis.md, and Medical Economics magazine. To learn more about Suzanne, visit www.suzannebujara.com and www.linkedin.com/in/suzannebujara.

All articles by Suzanne Bujara

Pulmonary Vasculature

Drug-Induced Pulmonary Arterial Hypertension: A More Complicated Prognosis

Suzanne Bujara

April 24, 2019

The prognosis for patients with idiopathic pulmonary arterial hypertension is substantially worse than for patients with idiopathic PAH.

Medical students, doctors, hospital room

Vascular Medicine

Is It Time for Endocrinologists to Join the Vascular Care Team?

Suzanne Bujara

February 27, 2019

As the link between diabetes and PAD becomes more evident, clinicians can best serve patients with these comorbidities by working collaboratively to prevent serious complications.

Pulmonary Vasculature

Pulmonary Hypertension Screening Adaptations for Adult Congenital Heart Disease

Suzanne Bujara

December 28, 2018

Because standardized approaches for echocardiographic screening are impractical for certain subgroups of people with congenital heart disease, experts offered screening adaptations for pulmonary hypertension.

Dyslipidemia

Familial Hypercholesterolemia: An Underdiagnosed Disease Gets a Second Look

Suzanne Bujara

December 26, 2018

Despite the frequency with which it occurs, familial hypercholesterolemia often goes undiagnosed, with only 10% of affected patients aware of this genetic disorder.

Prevention

Bipolar Disorder and the Cardiovascular System

Suzanne Bujara

September 28, 2018

Screening for cardiovascular disease risk is recommended for clinicians who manage patients with bipolar disorder.

A cholesterol atheroma is causing a narrowing of an artery.

Metabolic

PCSK9 Inhibition: Benefits Outweigh Risks in Patients With Diabetes

Suzanne Bujara

September 21, 2018

Statin therapy is the first line of defense against high LDL-C and the risk for atherosclerotic cardiovascular disease, the leading cause of morbidity and mortality in individuals with diabetes.

Dyslipidemia

Nutraceuticals May Benefit Patients Who Are Statin Intolerant

Suzanne Bujara

August 22, 2018

Nutraceuticals may offer a solution to patients who cannot tolerate statins because of severe muscle pain.

Stroke

Unraveling the Relationship Between COPD and Stroke

Suzanne Bujara

July 24, 2018

Although COPD has been identified as a risk factor for cardiovascular disease, researchers are less certain about the relationship between COPD and stroke.

systemic sclerosis systemic lupus erythematosus pulmonary arterial hypertension

Pulmonary Vasculature

Connective Tissue Diseases in Comorbid PAH: A Case for Separating SSc, SLE

Suzanne Bujara

May 30, 2018

Recent evidence suggests that systemic sclerosis and systemic lupus erythematosus comorbid with pulmonary arterial hypertension should be considered separate diseases.

Hypertension

Nonpsychotic Cannabinoids in Hypertension: Benefits and Harms

Suzanne Bujara

March 30, 2018

Despite public perception that cannabis is “natural” and “safe,” it has been implicated in many serious cardiovascular events, even in young, otherwise healthy people.

Next post in Hypertension